About Eric Carter, Ph.D., M.D.
Form D filings for Visgenx in 2023 list Eric Carter, Ph.D., M.D. as director.
Eric Carter, Ph.D., M.D. first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Eric Carter, Ph.D., M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Eric Carter, Ph.D., M.D. works with at each company, as listed on that company's latest Form D.
Visgenx, Inc. · Form D, Jun 14, 2023
MD
Martin Emanuele, Ph.D.
Executive officer and director
TD
Thomas Meier, Ph.D., M.D.
Director
ED
Elaine Heron, Ph.D.
Director
WP
William Pedranti
Chief Executive Officer and director
AB
Arthur Becker
Director
SD
Santosh Vetticaden, Ph.D., M.D.
Director